Diamyd Medical AB (publ) (STO:DMYD.B)

Diamyd Medical AB Revenue

Diamyd Medical AB had revenue of 99.00K SEK in the quarter ending February 28, 2026, with 15.12% growth. This brings the company's revenue in the last twelve months to 362.00K, up 98.90% year-over-year. In the fiscal year ending August 31, 2025, Diamyd Medical AB had annual revenue of 130.00K.

• Revenue (ttm): 362.00K
• Revenue Growth: +98.90%
• P/S Ratio: 530.89
• Revenue / Employee: 8.83K
• Employees: 41
• Market Cap: 192.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	130.00K	-	-
Aug 31, 2024	130.00K	-416.00K	-76.19%
Aug 31, 2023	546.00K	92.00K	20.26%
Aug 31, 2022	454.00K	201.00K	79.45%
Aug 31, 2021	253.00K	-88.00K	-25.81%

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error